Sustained drug delivery implant

Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release durat...

Full description

Saved in:
Bibliographic Details
Main Authors Shiah, Jane Guo, Pujara, Chetan P
Format Patent
LanguageEnglish
Published 21.02.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.
Bibliography:Application Number: AU20140216112